Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GALT | AKBA | NATR | ||
| Company | Galectin Therapeutic | Akebia Therapeutics | Nature S Sunshine | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.28 | 1.5900 | 21.17 | ||
| High | 6.66 | 1.6000 | 22.31 | ||
| Low | 5.67 | 1.5300 | 20.34 | ||
| Latest | 5.74 | 1.5400 | 21.88 | ||
| Change | -0.56 | -0.0500 | +0.71 | ||
| % Change | -8.89% | -3.14% | +3.35% | ||
| Volume | 774,100 | 2,202,000 | 176,800 | ||
| 20-Day Average Volume | 401,170 | 4,956,030 | 188,075 | ||
| Previous Close | 6.30 | 1.5900 | 21.17 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.66 | 1.6450 | 20.54 | ||
| 20-Day Raw Stochastic | 42.86% | 15.20% | 93.21% | ||
| 20-Day Relative Strength | 53.61 | 34.27 | 69.94 | ||
| Weighted Alpha | +225.14 | -42.54 | +38.89 | ||
| Today's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Sell | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.17% since 11/28/25 | -2.53% since 11/28/25 | +6.32% since 11/28/25 | ||
| Low | 5.31 on 12/02/25 | 1.4450 on 12/02/25 | 20.34 on 12/05/25 | ||
| High | 6.66 on 12/05/25 | 1.6299 on 12/01/25 | 22.31 on 12/05/25 | ||
| 1-Month | |||||
| %Chg | +1.95% since 11/05/25 | -27.36% since 11/05/25 | +54.85% since 11/05/25 | ||
| Low | 5.05 on 11/07/25 | 1.4450 on 12/02/25 | 13.58 on 11/06/25 | ||
| High | 6.66 on 12/05/25 | 2.1100 on 11/06/25 | 22.31 on 12/05/25 | ||
| 3-Month | |||||
| %Chg | +24.78% since 09/05/25 | -47.97% since 09/05/25 | +27.65% since 09/05/25 | ||
| Low | 4.08 on 09/30/25 | 1.4450 on 12/02/25 | 12.97 on 10/31/25 | ||
| High | 6.66 on 12/05/25 | 3.2000 on 10/28/25 | 22.31 on 12/05/25 | ||
| 6-Month | |||||
| %Chg | +341.54% since 06/05/25 | -58.27% since 06/05/25 | +50.27% since 06/05/25 | ||
| Low | 1.28 on 06/09/25 | 1.4450 on 12/02/25 | 12.97 on 10/31/25 | ||
| High | 6.66 on 12/05/25 | 4.0787 on 07/11/25 | 22.31 on 12/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 406,180 | 421,932 | 370,390 | ||
| Shares Outstanding, K | 64,473 | 265,366 | 17,496 | ||
| Annual Sales | 0 | 160,180,000 | 454,360,000 | ||
| Annual Net Income | -47,050,000 | -69,410,000 | 7,700,000 | ||
| Last Quarter Sales | 0 | 58,770,000 | 128,340,000 | ||
| Last Quarter Net Income | -8,180,000 | 540,000 | 5,330,000 | ||
| 60-Month Beta | 0.95 | 0.31 | 0.98 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 11/14/25 | 0.00 on 11/10/25 | 0.36 on 11/06/25 | ||
| Latest Earnings Date | 11/13/25 | 11/10/25 | 11/06/25 | ||
| Most Recent Dividend | N/A | N/A | 0.100 on 03/20/17 | ||
| Next Ex-Dividends Date | N/A | N/A | 03/20/17 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 21.98 | ||